Tech Company Financing Transactions

Apexigen Funding Round

Decheng Capital, Ocean Pine Healthcare Fund and private investors participated in a $65 million Series C funding round for Apexigen. The round was announced on 3/25/2020.

Transaction Overview

Company Name
Apexigen
Announced On
3/25/2020
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series C
Investors

Decheng Capital (Lead Investor)

Ocean Pine Healthcare Fund (Lead Investor)

Proceeds Purpose
Apexigen intends to use these proceeds to support the ongoing clinical development of its lead immunotherapeutic, APX005M, a monoclonal antibody targeting CD40.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
75 Shoreway Rd. C
Burlingame, CA 94070
USA
Phone
(650) 931-6236
Website
www.apexigen.com
Email Address
[email protected]
Overview
Apexigen is a biopharmaceutical product development company developing products to address life-threatening and difficult to treat diseases.
Profile
Apexigen LinkedIn Company Profile
Social Media
Apexigen Company Twitter Account
Company News
Apexigen News
Facebook
Apexigen on Facebook
YouTube
Apexigen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Xiaodong Yang
  Xiaodong Yang LinkedIn Profile  Xiaodong Yang Twitter Account  Xiaodong Yang News  Xiaodong Yang on Facebook
Chief Financial Officer
Linda Rubinstein
  Linda Rubinstein LinkedIn Profile  Linda Rubinstein Twitter Account  Linda Rubinstein News  Linda Rubinstein on Facebook
Chief Medical Officer
Ovid Trifan
  Ovid Trifan LinkedIn Profile  Ovid Trifan Twitter Account  Ovid Trifan News  Ovid Trifan on Facebook
Vice President
Rena Bahjat
  Rena Bahjat LinkedIn Profile  Rena Bahjat Twitter Account  Rena Bahjat News  Rena Bahjat on Facebook
Vice President
Thomas Jahn
  Thomas Jahn LinkedIn Profile  Thomas Jahn Twitter Account  Thomas Jahn News  Thomas Jahn on Facebook
Vice President
Jason Wright
  Jason Wright LinkedIn Profile  Jason Wright Twitter Account  Jason Wright News  Jason Wright on Facebook
VP - Bus. Development
Mark Nevins
  Mark Nevins LinkedIn Profile  Mark Nevins Twitter Account  Mark Nevins News  Mark Nevins on Facebook
VP - Finance
Amy Wong
  Amy Wong LinkedIn Profile  Amy Wong Twitter Account  Amy Wong News  Amy Wong on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/25/2020: Nature's Fynd venture capital transaction
Next: 3/25/2020: ClinOne venture capital transaction

 

Share this article

 

About Database of VC Transactions

Our team works diligently to report on tech company VC transactions. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.